Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novavax | NVAX | Sep 30, 2024 | 12.63 | -5.04 |
Novo Integrated Sciences | NVOS | Sep 30, 2024 | 0.28 | -4.42 |
Novo Nordisk ADR | NVO | Sep 30, 2024 | 119.07 | -1.40 |
NovoCure | NVCR | Sep 30, 2024 | 15.63 | +0.13 |
Novonix ADR | NVX | Sep 30, 2024 | 1.84 | -5.64 |
NRG Energy | NRG | Sep 30, 2024 | 91.10 | -0.13 |
NRx Pharmaceuticals | NRXP | Sep 30, 2024 | 1.69 | -3.43 |
NSTS Bancorp | NSTS | Sep 30, 2024 | 10.35 | -0.67 |
Nu Holdings | NU | Sep 30, 2024 | 13.65 | -1.59 |
Nu Skin Enterprises | NUS | Sep 30, 2024 | 7.37 | +0.14 |
Nuburu | BURU | Sep 30, 2024 | 0.51 | +1.19 |
NuCana ADR | NCNA | Sep 30, 2024 | 2.30 | -6.12 |
Nucor | NUE | Sep 30, 2024 | 150.34 | +0.14 |
Nukkleus | NUKK | Sep 30, 2024 | 0.29 | -18.14 |
Nurix Therapeutics | NRIX | Sep 30, 2024 | 22.47 | -2.52 |
NuScale Power | SMR | Sep 30, 2024 | 11.58 | -7.73 |
Nustar Energy C Pref | NS-C | Sep 30, 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | Sep 30, 2024 | 59.25 | -0.60 |
Nutex Health | NUTX | Sep 30, 2024 | 21.70 | +11.28 |
Nutriband | NTRB | Sep 30, 2024 | 6.05 | +0.67 |
Nutrien | NTR | Sep 30, 2024 | 48.06 | -0.39 |
Nuvalent A | NUVL | Sep 30, 2024 | 102.30 | +3.23 |
Nuvation Bio A | NUVB | Sep 30, 2024 | 2.29 | -4.18 |
Nuvectis Pharma | NVCT | Sep 30, 2024 | 6.29 | +1.78 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Sep 30, 2024 | 13.39 | +0.30 |
Nuveen Amtfree Municipal Value Fund | NUW | Sep 30, 2024 | 14.22 | +0.35 |
Nuveen Amtfree Quality Municipal Income Fund | NEA | Sep 30, 2024 | 11.97 | +0.17 |
Nuveen Arizona Quality Municipal Fund | NAZ | Sep 30, 2024 | 11.82 | +0.51 |
Nuveen California Amtfree Quality Municipal Income Fund | NKX | Sep 30, 2024 | 13.59 | +0.15 |
Nuveen California Municipal Value Fund | NCA | Sep 30, 2024 | 9.12 | +0.39 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.